glutamic acid has been researched along with ici 118551 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartoccini, F; Carminati, P; Castorina, M; Di Cesare, MA; Di Serio, S; Gallo, G; Ghirardi, O; Giorgi, F; Giorgi, L; Minetti, P; Piersanti, G; Tarzia, G; Tinti, MO | 1 |
| Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
| Ehle, B; Kaumann, AJ; Lemoine, H | 1 |
| Goadsby, PJ; Shields, KG | 1 |
| Feinstein, DL; Kalinin, S; Leza, JC; Madrigal, JL; Polak, P | 1 |
| Cambron, M; De Keyser, J; Demol, F; Kooijman, R; Laureys, G; Muscat, R; Valentino, M; Zammit, C | 1 |
6 other study(ies) available for glutamic acid and ici 118551
| Article | Year |
|---|---|
2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.
Topics: Adenine; Adenosine A2 Receptor Antagonists; Animals; Cell Line; Cricetinae; Cricetulus; Drug Design; Humans; Imidazoles; Male; Models, Molecular; Motor Activity; Purines; Radioligand Assay; Rats; Rats, Inbred F344; Structure-Activity Relationship; Triazoles | 2005 |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
Direct labelling of beta 2-adrenoceptors. Comparison of binding potency of 3H-ICI 118,551 and blocking potency of ICI 118,551.
Topics: Adrenergic beta-Antagonists; Animals; Bisoprolol; Bupranolol; Female; Fumarates; Glutamates; Glutamic Acid; Guinea Pigs; In Vitro Techniques; Kinetics; Lung; Male; Membranes; Myocardium; Propanolamines; Pyruvates; Pyruvic Acid; Receptors, Adrenergic, beta; Sinoatrial Node; Trachea | 1985 |
Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Electric Stimulation; Glutamic Acid; Iontophoresis; Isoproterenol; Male; Migraine Disorders; Neural Inhibition; Piperazines; Procaterol; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Somatosensory Cortex; Synaptic Transmission; Trigeminal Nerve; Ventral Thalamic Nuclei | 2005 |
Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline.
Topics: Adenosine Triphosphate; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Astrocytes; Calcium; Cell Survival; Cells, Cultured; Cerebral Cortex; Chemokine CCL2; Coculture Techniques; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Glucose; Glutamic Acid; Hypoxia; L-Lactate Dehydrogenase; Microglia; N-Methylaspartate; Neurons; Neuroprotective Agents; Norepinephrine; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transfection | 2009 |
β₂-adrenergic receptors protect axons during energetic stress but do not influence basal glio-axonal lactate shuttling in mouse white matter.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Animals; Axons; Central Nervous System Agents; Cerebellum; Clenbuterol; Corpus Callosum; Coumaric Acids; Glutamic Acid; Lactic Acid; Male; Mice, Inbred C57BL; Neuroglia; Propanolamines; Receptors, Adrenergic, beta-2; Stress, Physiological; White Matter | 2014 |